Fossmo HL, Ellefsen-Martinsen M, Ørstavik K, Arora T, Frich JC, Robinson HS (2025)
Psychometric properties of MFM32 in Myotonic Dystrophy type 1
Arch Phys Med Rehabil (in press)
DOI 10.1016/j.apmr.2025.10.013, PubMed 41192792

Aamodt AH, Ueland T, Boldingh M, Bezgal BE, Argren MB, Dunne CA, Otterdal K, Gregersen I, Bjerkeli V, Michelsen AE, Husøy A, Morsund ÅH, Devik K, Poole AC, Gjendemsjø KB, Schlüter K, Mathisen SM, Aalstad-Johansen M, Skattør TH, Sønnervik J, Boye TB, Popperud TH, Høgestøl EA, Harbo HF, Lund-Johansen F et al. (2025)
Altered amyloid plasma profile in patients with disabling headaches after SARS-CoV-2 infection and vaccination
BMJ Neurol Open, 7 (2), e001013
DOI 10.1136/bmjno-2024-001013, PubMed 40881041

Allergodt K, Werlauff U, Dreyer P, Ørstavik K, Handberg C (2025)
Living and coping with adult-onset myotonic dystrophy type 1 from the perspectives of caregivers
Disabil Rehabil, 1-13 (in press)
DOI 10.1080/09638288.2025.2547688, PubMed 40842110